SCHEMBL21565697

SCHEMBL21565697

CC(C)c1cncnc1-c1ccc2[nH]cnc2c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM5B Q9UGL1 1/20 0.37
QPCT Q16769 4/20 0.36
QPCTL Q9NXS2 3/20 0.36
PIK3CD O00329 2/20 0.32
PIK3CA P42336 2/20 0.32
PIK3CB P42338 2/20 0.32
MTOR P42345 2/20 0.32
PIK3CG P48736 2/20 0.32
ABL1 P00519 1/20 0.32
EGFR P00533 1/20 0.32
HCK P08631 1/20 0.32
SRC P12931 1/20 0.32
KDR P35968 1/20 0.32
EPHB4 P54760 1/20 0.32
PRKDC P78527 1/20 0.32
TDO2 P48775 1/20 0.32
MAPK9 P45984 1/20 0.32
MAPK10 P53779 1/20 0.32
KDM4E B2RXH2 1/20 0.32
ALDH1A1 P00352 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21387779 0.85 QPCT (0.38) QPCTQPCTLKDRTDO2KDM4E
SCHEMBL21565690 0.78 QPCT (0.36) KDM5BQPCTQPCTLTDO2KDM4E
SCHEMBL21565693 0.76 KDM5B (0.37) KDM5BQPCTQPCTLPIK3CDPIK3CA
SCHEMBL23123086 0.75 QPCT (0.51) QPCTQPCTLTDO2KDM4EALDH1A1
SCHEMBL21565626 0.73 ABL1 (0.51) PIK3CDPIK3CAPIK3CBMTORPIK3CG
SCHEMBL25912031 0.72 QPCT (0.39) KDM5BQPCTQPCTLKDM4EALDH1A1
SCHEMBL6008269 0.72 MAPT (0.50) QPCTQPCTLKDM4EALDH1A1MAPT
SCHEMBL31143361 0.72 MAPT (0.50) QPCTQPCTLKDM4EALDH1A1MAPT
SCHEMBL21387732 0.71 BRD4 (0.40) KDM5BQPCTQPCTLKDRKDM4E
SCHEMBL2810219 0.71 QPCT (0.41) QPCTQPCTLKDM4EALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190343802-A1 CELL-PROTECTIVE COMPOUNDS AND THEIR USE ETH Zürich (CH) 2019-11-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190343802-A1 CELL-PROTECTIVE COMPOUNDS AND THEIR USE SRPK2, SRSF2, SRPK1 KDM5B 4578/4885QPCT 4373/4885QPCTL 4255/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.